回答 1. 解释“current license is non-compliant for [jdbc]”的含义 该错误消息 "current license is non-compliant for [jdbc]" 表示您当前使用的 Elasticsearch 集群的许可证不允许使用 JDBC 功能。JDBC(Java Database Connectivity)是一个Java API,用于数据库连接,但并非所有版本的 Elasticsearch 或其 JDBC 驱...
current license is non-compliant for security 二、查看许可证 代码语言:shell 复制 curl -u 'elastic:$PWD' http://$ES_ENDPOINT/_xpack/license?pretty # 返回信息 { "license" : { "status" : "expired", "uid" : "94f59e8d-ef66-46bf-adc3-655800eb1a6e", "type" : "trial", "issue_date...
"current license is non-compliant for [security]","error.stack_trace":"org.elasticsearch.ElasticsearchSecurityException: current license is non-compliant for [security]\n\tat org.elasticsearch.xcore@8.8.2/org.elasticsearch.license.LicenseUtils.newComplianceException(LicenseUtils.java:40)\n\tat org....
1、问题 通过dbeaver 配置 jdbc 连接 es时报错 current license is non-compliant for [jdbc] 2、原因 https://blog.csdn.net/ctypyb2002/article/details/106115691 3、JDBC Client下载版本 https://www.elastic.co/cn/downloads/past-releases/jdbc-client-7-5-0 参考链接: https://www.elastic.co/cn/do...
51CTO博客已为您找到关于current license is non-compliant for [jdbc]的相关内容,包含IT学习相关文档代码介绍、相关教程视频课程,以及current license is non-compliant for [jdbc]问答内容。更多current license is non-compliant for [jdbc]相关解答可以来51CTO博客参与
【原】org.elasticsearch.ElasticsearchSecurityException: current license is non-compliant for [security] 报错信息描述如下: image.png 大概看了下,百度了一下,说的应该是身份授权过期问题,需要注册一个Elasticsearch的用户,得到一个授权的json文件,就可以把授权日期延期一年了。
51CTO博客已为您找到关于current license is non-compliant for [security]的相关内容,包含IT学习相关文档代码介绍、相关教程视频课程,以及current license is non-compliant for [security]问答内容。更多current license is non-compliant for [security]相关解答可以来51
ES7.x许可证过期 ElasticsearchSecurityException: current license is non-compliant for [security] ES7的X-pack许可证是提供免费一个月的试用,但是到期之后,就会隔一段时间报这个错误 elasticsearch_1 | {"type": "server", "timestamp": "2020-09-09T04:14:51,347Z", "level": "ERROR", "component": ...
Notably, two CAR-T cell products that target CD19, Kymriah and Yescarta, have received approval for the treatment of lymphoma or leukemia that is positive for CD19 [4]. The progress of CAR-T cell therapy in hematologic malignancies has spurred the development of CAR-T cell therapy for ...
For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess. ...